 | • レポートコード：MRC2102QY9473 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の重症筋無力症治療薬市場について種類別（抗コリンエステラーゼ、免疫抑制剤、静脈内免疫グロブリン）、用途別（病院、クリニック）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・重症筋無力症治療薬市場の概要 ・世界の主要地域別重症筋無力症治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の重症筋無力症治療薬市場規模2015-2026：種類別（抗コリンエステラーゼ、免疫抑制剤、静脈内免疫グロブリン） ・世界の重症筋無力症治療薬市場規模2015-2026：用途別（病院、クリニック） ・重症筋無力症治療薬の米国市場規模2015-2020 ・重症筋無力症治療薬のヨーロッパ市場規模2015-2020 ・重症筋無力症治療薬の中国市場規模2015-2020 ・重症筋無力症治療薬の日本市場規模2015-2020 ・重症筋無力症治療薬の東南アジア市場規模2015-2020 ・重症筋無力症治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・重症筋無力症治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・重症筋無力症治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Myasthenia Gravis Drugs Market
The global Myasthenia Gravis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Myasthenia Gravis Drugs Scope and Market Size
The global Myasthenia Gravis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Myasthenia Gravis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Myasthenia Gravis Drugs market is segmented into
Anticholinesterases
Immunosuppressants
Intravenous Immune Globulins
Segment by Application, the Myasthenia Gravis Drugs market is segmented into
Hospitals
Clinics
The Myasthenia Gravis Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Myasthenia Gravis Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Myasthenia Gravis Drugs Market Share Analysis
Myasthenia Gravis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Myasthenia Gravis Drugs business, the date to enter into the Myasthenia Gravis Drugs market, Myasthenia Gravis Drugs product introduction, recent developments, etc.
The major vendors covered:
Flamel Technologies
F. Hoffmann-La Roche
Grifols
Pfizer
Takeda
Novartis
Bausch Health
Alexion Pharmaceuticals
Catalyst Pharmaceuticals
CSL
Curavac
Cytokinetics
Galencia
GlaxoSmithKline
Lupin Pharmaceuticals
Mitsubishi Tanabe Pharma
1 Myasthenia Gravis Drugs Market Overview
1.1 Myasthenia Gravis Drugs Product Scope
1.2 Myasthenia Gravis Drugs Segment by Type
1.2.1 Global Myasthenia Gravis Drugs Sales by Type (2020-2026)
1.2.2 Anticholinesterases
1.2.3 Immunosuppressants
1.2.4 Intravenous Immune Globulins
1.3 Myasthenia Gravis Drugs Segment by Application
1.3.1 Global Myasthenia Gravis Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Myasthenia Gravis Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Myasthenia Gravis Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Myasthenia Gravis Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Myasthenia Gravis Drugs Price Trends (2015-2026)
2 Myasthenia Gravis Drugs Estimate and Forecast by Region
2.1 Global Myasthenia Gravis Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Myasthenia Gravis Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Myasthenia Gravis Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Myasthenia Gravis Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Myasthenia Gravis Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Myasthenia Gravis Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Myasthenia Gravis Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Myasthenia Gravis Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Myasthenia Gravis Drugs Estimates and Projections (2015-2026)
2.4.3 China Myasthenia Gravis Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Myasthenia Gravis Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Myasthenia Gravis Drugs Estimates and Projections (2015-2026)
2.4.6 India Myasthenia Gravis Drugs Estimates and Projections (2015-2026)
3 Global Myasthenia Gravis Drugs Competition Landscape by Players
3.1 Global Top Myasthenia Gravis Drugs Players by Sales (2015-2020)
3.2 Global Top Myasthenia Gravis Drugs Players by Revenue (2015-2020)
3.3 Global Myasthenia Gravis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis Drugs as of 2019)
3.4 Global Myasthenia Gravis Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Myasthenia Gravis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Myasthenia Gravis Drugs Players (Opinion Leaders)
4 Global Myasthenia Gravis Drugs Market Size by Type
4.1 Global Myasthenia Gravis Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Myasthenia Gravis Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Myasthenia Gravis Drugs Price by Type (2015-2020)
4.2 Global Myasthenia Gravis Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Myasthenia Gravis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Myasthenia Gravis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Myasthenia Gravis Drugs Price Forecast by Type (2021-2026)
5 Global Myasthenia Gravis Drugs Market Size by Application
5.1 Global Myasthenia Gravis Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Myasthenia Gravis Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Myasthenia Gravis Drugs Price by Application (2015-2020)
5.2 Global Myasthenia Gravis Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Myasthenia Gravis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Myasthenia Gravis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Myasthenia Gravis Drugs Price Forecast by Application (2021-2026)
6 United States Myasthenia Gravis Drugs Market Facts & Figures
6.1 United States Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
6.2 United States Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
6.3 United States Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
7 Europe Myasthenia Gravis Drugs Market Facts & Figures
7.1 Europe Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
8 China Myasthenia Gravis Drugs Market Facts & Figures
8.1 China Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
8.2 China Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
8.3 China Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
9 Japan Myasthenia Gravis Drugs Market Facts & Figures
9.1 Japan Myasthenia Gravis Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Myasthenia Gravis Drugs Market Facts & Figures
10.1 Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
11 India Myasthenia Gravis Drugs Market Facts & Figures
11.1 India Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
11.2 India Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
11.3 India Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Myasthenia Gravis Drugs Business
12.1 Flamel Technologies
12.1.1 Flamel Technologies Corporation Information
12.1.2 Flamel Technologies Business Overview
12.1.3 Flamel Technologies Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Flamel Technologies Myasthenia Gravis Drugs Products Offered
12.1.5 Flamel Technologies Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Corporation Information
12.2.2 F. Hoffmann-La Roche Business Overview
12.2.3 F. Hoffmann-La Roche Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 F. Hoffmann-La Roche Myasthenia Gravis Drugs Products Offered
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 Grifols
12.3.1 Grifols Corporation Information
12.3.2 Grifols Business Overview
12.3.3 Grifols Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Grifols Myasthenia Gravis Drugs Products Offered
12.3.5 Grifols Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Myasthenia Gravis Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 Takeda
12.5.1 Takeda Corporation Information
12.5.2 Takeda Business Overview
12.5.3 Takeda Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Takeda Myasthenia Gravis Drugs Products Offered
12.5.5 Takeda Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Myasthenia Gravis Drugs Products Offered
12.6.5 Novartis Recent Development
12.7 Bausch Health
12.7.1 Bausch Health Corporation Information
12.7.2 Bausch Health Business Overview
12.7.3 Bausch Health Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bausch Health Myasthenia Gravis Drugs Products Offered
12.7.5 Bausch Health Recent Development
12.8 Alexion Pharmaceuticals
12.8.1 Alexion Pharmaceuticals Corporation Information
12.8.2 Alexion Pharmaceuticals Business Overview
12.8.3 Alexion Pharmaceuticals Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Alexion Pharmaceuticals Myasthenia Gravis Drugs Products Offered
12.8.5 Alexion Pharmaceuticals Recent Development
12.9 Catalyst Pharmaceuticals
12.9.1 Catalyst Pharmaceuticals Corporation Information
12.9.2 Catalyst Pharmaceuticals Business Overview
12.9.3 Catalyst Pharmaceuticals Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Catalyst Pharmaceuticals Myasthenia Gravis Drugs Products Offered
12.9.5 Catalyst Pharmaceuticals Recent Development
12.10 CSL
12.10.1 CSL Corporation Information
12.10.2 CSL Business Overview
12.10.3 CSL Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSL Myasthenia Gravis Drugs Products Offered
12.10.5 CSL Recent Development
12.11 Curavac
12.11.1 Curavac Corporation Information
12.11.2 Curavac Business Overview
12.11.3 Curavac Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Curavac Myasthenia Gravis Drugs Products Offered
12.11.5 Curavac Recent Development
12.12 Cytokinetics
12.12.1 Cytokinetics Corporation Information
12.12.2 Cytokinetics Business Overview
12.12.3 Cytokinetics Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Cytokinetics Myasthenia Gravis Drugs Products Offered
12.12.5 Cytokinetics Recent Development
12.13 Galencia
12.13.1 Galencia Corporation Information
12.13.2 Galencia Business Overview
12.13.3 Galencia Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Galencia Myasthenia Gravis Drugs Products Offered
12.13.5 Galencia Recent Development
12.14 GlaxoSmithKline
12.14.1 GlaxoSmithKline Corporation Information
12.14.2 GlaxoSmithKline Business Overview
12.14.3 GlaxoSmithKline Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 GlaxoSmithKline Myasthenia Gravis Drugs Products Offered
12.14.5 GlaxoSmithKline Recent Development
12.15 Lupin Pharmaceuticals
12.15.1 Lupin Pharmaceuticals Corporation Information
12.15.2 Lupin Pharmaceuticals Business Overview
12.15.3 Lupin Pharmaceuticals Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Lupin Pharmaceuticals Myasthenia Gravis Drugs Products Offered
12.15.5 Lupin Pharmaceuticals Recent Development
12.16 Mitsubishi Tanabe Pharma
12.16.1 Mitsubishi Tanabe Pharma Corporation Information
12.16.2 Mitsubishi Tanabe Pharma Business Overview
12.16.3 Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Products Offered
12.16.5 Mitsubishi Tanabe Pharma Recent Development
13 Myasthenia Gravis Drugs Manufacturing Cost Analysis
13.1 Myasthenia Gravis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Myasthenia Gravis Drugs
13.4 Myasthenia Gravis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Myasthenia Gravis Drugs Distributors List
14.3 Myasthenia Gravis Drugs Customers
15 Market Dynamics
15.1 Myasthenia Gravis Drugs Market Trends
15.2 Myasthenia Gravis Drugs Opportunities and Drivers
15.3 Myasthenia Gravis Drugs Market Challenges
15.4 Myasthenia Gravis Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Myasthenia Gravis Drugs Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Myasthenia Gravis Drugs Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Myasthenia Gravis Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Myasthenia Gravis Drugs Sales (MT) by Region (2015-2020)
Table 5. Global Myasthenia Gravis Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Myasthenia Gravis Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Myasthenia Gravis Drugs Revenue Share by Region (2015-2020)
Table 8. Global Myasthenia Gravis Drugs Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Myasthenia Gravis Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Myasthenia Gravis Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Myasthenia Gravis Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Myasthenia Gravis Drugs (MT) of Key Companies (2015-2020)
Table 13. Global Myasthenia Gravis Drugs Sales Share by Company (2015-2020)
Table 14. Global Myasthenia Gravis Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Myasthenia Gravis Drugs Revenue Share by Company (2015-2020)
Table 16. Global Myasthenia Gravis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis Drugs as of 2019)
Table 17. Global Myasthenia Gravis Drugs Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Myasthenia Gravis Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Myasthenia Gravis Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Myasthenia Gravis Drugs Players
Table 22. Global Myasthenia Gravis Drugs Sales (MT) by Type (2015-2020)
Table 23. Global Myasthenia Gravis Drugs Sales Share by Type (2015-2020)
Table 24. Global Myasthenia Gravis Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Myasthenia Gravis Drugs Price (MT) by Type (2015-2020)
Table 26. Global Myasthenia Gravis Drugs Sales Share by Type (2021-2026)
Table 27. Global Myasthenia Gravis Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Myasthenia Gravis Drugs Revenue Share by Type (2021-2026)
Table 29. Global Myasthenia Gravis Drugs Price (MT) by Type (2021-2026)
Table 30. Global Myasthenia Gravis Drugs Sales (MT) by Application (2015-2020)
Table 31. Global Myasthenia Gravis Drugs Sales Share by Application (2015-2020)
Table 32. Global Myasthenia Gravis Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Myasthenia Gravis Drugs Price (MT) by Application (2015-2020)
Table 34. Global Myasthenia Gravis Drugs Sales (MT) by Application (2021-2026)
Table 35. Global Myasthenia Gravis Drugs Sales Share by Application (2021-2026)
Table 36. Global Myasthenia Gravis Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Myasthenia Gravis Drugs Revenue Share by Application (2021-2026)
Table 38. Global Myasthenia Gravis Drugs Price (MT) by Application (2021-2026)
Table 39. United States Myasthenia Gravis Drugs Sales (MT) by Company (2015-2020)
Table 40. United States Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Myasthenia Gravis Drugs Sales (MT) by Type (2015-2020)
Table 42. United States Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Myasthenia Gravis Drugs Sales (MT) by Application (2015-2020)
Table 44. United States Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Myasthenia Gravis Drugs Sales (MT) by Company (2015-2020)
Table 46. Europe Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Myasthenia Gravis Drugs Sales (MT) by Type (2015-2020)
Table 48. Europe Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Myasthenia Gravis Drugs Sales (MT) by Application (2015-2020)
Table 50. Europe Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
Table 51. China Myasthenia Gravis Drugs Sales (MT) by Company (2015-2020)
Table 52. China Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
Table 53. China Myasthenia Gravis Drugs Sales (MT) by Type (2015-2020)
Table 54. China Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
Table 55. China Myasthenia Gravis Drugs Sales (MT) by Application (2015-2020)
Table 56. China Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Myasthenia Gravis Drugs Sales (MT) by Company (2015-2020)
Table 58. Japan Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Myasthenia Gravis Drugs Sales (MT) by Type (2015-2020)
Table 60. Japan Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Myasthenia Gravis Drugs Sales (MT) by Application (2015-2020)
Table 62. Japan Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Myasthenia Gravis Drugs Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Myasthenia Gravis Drugs Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Myasthenia Gravis Drugs Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
Table 69. India Myasthenia Gravis Drugs Sales (MT) by Company (2015-2020)
Table 70. India Myasthenia Gravis Drugs Sales Market Share by Company (2015-2020)
Table 71. India Myasthenia Gravis Drugs Sales (MT) by Type (2015-2020)
Table 72. India Myasthenia Gravis Drugs Sales Market Share by Type (2015-2020)
Table 73. India Myasthenia Gravis Drugs Sales (MT) by Application (2015-2020)
Table 74. India Myasthenia Gravis Drugs Sales Market Share by Application (2015-2020)
Table 75. Flamel Technologies Corporation Information
Table 76. Flamel Technologies Description and Business Overview
Table 77. Flamel Technologies Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. Flamel Technologies Myasthenia Gravis Drugs Product
Table 79. Flamel Technologies Recent Development
Table 80. F. Hoffmann-La Roche Corporation Information
Table 81. F. Hoffmann-La Roche Description and Business Overview
Table 82. F. Hoffmann-La Roche Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. F. Hoffmann-La Roche Myasthenia Gravis Drugs Product
Table 84. F. Hoffmann-La Roche Recent Development
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Grifols Myasthenia Gravis Drugs Product
Table 89. Grifols Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Pfizer Myasthenia Gravis Drugs Product
Table 94. Pfizer Recent Development
Table 95. Takeda Corporation Information
Table 96. Takeda Description and Business Overview
Table 97. Takeda Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Takeda Myasthenia Gravis Drugs Product
Table 99. Takeda Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Novartis Myasthenia Gravis Drugs Product
Table 104. Novartis Recent Development
Table 105. Bausch Health Corporation Information
Table 106. Bausch Health Description and Business Overview
Table 107. Bausch Health Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Bausch Health Myasthenia Gravis Drugs Product
Table 109. Bausch Health Recent Development
Table 110. Alexion Pharmaceuticals Corporation Information
Table 111. Alexion Pharmaceuticals Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Alexion Pharmaceuticals Description and Business Overview
Table 113. Alexion Pharmaceuticals Myasthenia Gravis Drugs Product
Table 114. Alexion Pharmaceuticals Recent Development
Table 115. Catalyst Pharmaceuticals Corporation Information
Table 116. Catalyst Pharmaceuticals Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Catalyst Pharmaceuticals Description and Business Overview
Table 118. Catalyst Pharmaceuticals Myasthenia Gravis Drugs Product
Table 119. Catalyst Pharmaceuticals Recent Development
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. CSL Myasthenia Gravis Drugs Product
Table 124. CSL Recent Development
Table 125. Curavac Corporation Information
Table 126. Curavac Description and Business Overview
Table 127. Curavac Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Curavac Myasthenia Gravis Drugs Product
Table 129. Curavac Recent Development
Table 130. Cytokinetics Corporation Information
Table 131. Cytokinetics Description and Business Overview
Table 132. Cytokinetics Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Cytokinetics Myasthenia Gravis Drugs Product
Table 134. Cytokinetics Recent Development
Table 135. Galencia Corporation Information
Table 136. Galencia Description and Business Overview
Table 137. Galencia Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Galencia Myasthenia Gravis Drugs Product
Table 139. Galencia Recent Development
Table 140. GlaxoSmithKline Corporation Information
Table 141. GlaxoSmithKline Description and Business Overview
Table 142. GlaxoSmithKline Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. GlaxoSmithKline Myasthenia Gravis Drugs Product
Table 144. GlaxoSmithKline Recent Development
Table 145. Lupin Pharmaceuticals Corporation Information
Table 146. Lupin Pharmaceuticals Description and Business Overview
Table 147. Lupin Pharmaceuticals Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 148. Lupin Pharmaceuticals Myasthenia Gravis Drugs Product
Table 149. Lupin Pharmaceuticals Recent Development
Table 150. Mitsubishi Tanabe Pharma Corporation Information
Table 151. Mitsubishi Tanabe Pharma Description and Business Overview
Table 152. Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 153. Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Product
Table 154. Mitsubishi Tanabe Pharma Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Myasthenia Gravis Drugs Distributors List
Table 158. Myasthenia Gravis Drugs Customers List
Table 159. Myasthenia Gravis Drugs Market Key Trends
Table 160. Myasthenia Gravis Drugs Key Opportunities and Drivers
Table 161. Myasthenia Gravis Drugs Market Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Myasthenia Gravis Drugs Product Picture
Figure 2. Global Myasthenia Gravis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Myasthenia Gravis Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Global Myasthenia Gravis Drugs Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Myasthenia Gravis Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Myasthenia Gravis Drugs Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Myasthenia Gravis Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Myasthenia Gravis Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Myasthenia Gravis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Myasthenia Gravis Drugs Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Myasthenia Gravis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Myasthenia Gravis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Myasthenia Gravis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Myasthenia Gravis Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Myasthenia Gravis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Myasthenia Gravis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Myasthenia Gravis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Myasthenia Gravis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Myasthenia Gravis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Myasthenia Gravis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Myasthenia Gravis Drugs Players Market Share by Revenue in Myasthenia Gravis Drugs 2015 & 2019
Figure 26. Myasthenia Gravis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Myasthenia Gravis Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Myasthenia Gravis Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Myasthenia Gravis Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Myasthenia Gravis Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Myasthenia Gravis Drugs Sales Market Share by Type in 2019
Figure 32. United States Myasthenia Gravis Drugs Sales Market Share by Type in 2019
Figure 33. Europe Myasthenia Gravis Drugs Sales Market Share by Company in 2019
Figure 34. Europe Myasthenia Gravis Drugs Sales Market Share by Type in 2019
Figure 35. Europe Myasthenia Gravis Drugs Sales Market Share by Application in 2019
Figure 36. China Myasthenia Gravis Drugs Sales Market Share by Company in 2019
Figure 37. China Myasthenia Gravis Drugs Sales Market Share by Type in 2019
Figure 38. China Myasthenia Gravis Drugs Sales Market Share by Application in 2019
Figure 39. Japan Myasthenia Gravis Drugs Sales Market Share by Company in 2019
Figure 40. Japan Myasthenia Gravis Drugs Sales Market Share by Type in 2019
Figure 41. Japan Myasthenia Gravis Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Myasthenia Gravis Drugs Sales Market Share by Application in 2019
Figure 45. India Myasthenia Gravis Drugs Sales Market Share by Company in 2019
Figure 46. India Myasthenia Gravis Drugs Sales Market Share by Type in 2019
Figure 47. India Myasthenia Gravis Drugs Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Myasthenia Gravis Drugs
Figure 50. Manufacturing Process Analysis of Myasthenia Gravis Drugs
Figure 51. Myasthenia Gravis Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …- トレプロスチニル薬の世界市場レポート2020 Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8…
- 副腎白質ジストロフィー治療薬の世界市場レポート2020 Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a peroxisomal protein called adrenoleukodystrophy protein (ALDP). Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatt…
- 非ステロイド性抗炎症薬の世界市場レポート2020 Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune dis…
- アルツハイマー病治療薬の世界市場レポート2020 Market Analysis and Insights: Global Alzheimer's Drugs Market The global Alzheimer's Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Alzheimer's Drugs Scope and Market Size The global Alzheimer's Drugs market is s…